Kroger (KR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
3 Feb, 2026Executive summary
Achieved a solid start to Q1 2024 with grocery business outperforming expectations, offsetting weaker fuel and health and wellness results, and driving growth in households and customer visits through strong store execution and omni-channel experience.
Digital sales grew over 8% year-over-year, led by double-digit growth in delivery and pickup, with digitally engaged households up 9% and digital coupon downloads up 18%.
Launched new Field & Vine berry brand, introduced 346 new Our Brands items, and achieved record quarterly floral sales and pickup fill rate.
Alternative profit businesses, especially retail media and Kroger Precision Marketing, delivered strong growth and expanded capabilities, keeping on track for over 20% annual growth.
Announced sale of Kroger Specialty Pharmacy for $485 million, expected to close in H2 2024, and amended divestiture agreement with C&S Wholesale Grocers in connection with the proposed Albertsons merger.
Financial highlights
Q1 2024 sales were $45.3 billion, up 0.2% year-over-year; identical sales excluding fuel grew 0.5% year-over-year.
Operating profit was $1,294 million, down from $1,470 million year-over-year; adjusted FIFO operating profit was $1,499 million, down from $1,669 million.
Adjusted EPS was $1.43 per diluted share, down from $1.51 year-over-year; GAAP EPS was $1.29.
Gross margin was 22.4% of sales; FIFO gross margin rate (excluding fuel) decreased 7 basis points, mainly due to lower pharmacy margins and increased price investments.
LIFO charge was $41 million, down from $99 million in the prior year quarter, reflecting lower inflation expectations.
Outlook and guidance
Full-year 2024 guidance reaffirmed: identical sales without fuel growth of 0.25%–1.75%, adjusted FIFO operating profit of $4.6–$4.8 billion, and adjusted EPS of $4.30–$4.50.
Adjusted EPS for Q2 expected to decline at a rate similar to Q1, due to ongoing pharmacy profitability pressures.
Identical sales expected to improve throughout the year, aiming for the 2%-4% long-term model range by the second half.
Inflation expected to remain slightly above 1% for the year, stabilizing with no broad-based deflation.
Free cash flow forecasted at $2.5–$2.7 billion; capital expenditures at $3.4–$3.6 billion.
Latest events from Kroger
- Strong sales, margin gains, and eCommerce growth, with 2026 guidance signaling continued momentum.KR
Q4 20265 Mar 2026 - Dividend raised, strong sales, and all shareholder proposals defeated at the annual meeting.KR
AGM 20253 Feb 2026 - Q2 2024 delivered 1.2% sales growth, $0.93 EPS, and strong digital gains amid merger progress.KR
Q2 202520 Jan 2026 - Q3 digital and pharmacy gains offset lower fuel sales; Albertsons merger terminated, $7.5B buyback set.KR
Q3 202511 Jan 2026 - Strong 2024 sales and digital growth set the stage for further gains and capital returns in 2025.KR
Q4 20256 Jan 2026 - Q2 2025 delivered strong sales, margin growth, and raised guidance, led by eCommerce and pharmacy.KR
Q2 202615 Dec 2025 - Adjusted EPS rose 7% to $1.05, but a $2.6B impairment drove a net loss.KR
Q3 202612 Dec 2025 - Board recommends director elections, pay approval, auditor ratification, and opposes all shareholder proposals.KR
Proxy Filing1 Dec 2025 - Virtual meeting to vote on directors, pay, auditor, and key proposals; board supports all nominees.KR
Proxy Filing1 Dec 2025